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ICHTHYOSIS AND PROFILAGGRIN SYNTHESIS 
The Ichthyoses are a heterogeneous group of inherited skin 
diseases. clinically manifest by scaling. Alterations in epidermal 
structural proteins and in lipid biosynthesis have been suggested 
as possible underlying defects in various ichthyoses. Studies in 
our laboratories have focused on the role of profUaggrin and 
filaggrin . Filaggrin is a keratin intexmediate filament-associated 
protein derived from profJ.1aggrin (proFG). a precursor expressed 
in the granular layer. ProFG is enzymatically processed to 
fUaggrin, which aggregates keratin filaments in the lower stratum 
corneum and is then proteolyzed to component amino acids which 
act as humectants. 
In types I and II Harlequin Ichthyosis proFG is expressed but 
not processed to fJ.1aggrin, while in type III, the protein is not 
expressed. In CHll..D syndrome, proFG expression along with that 
of Kl and KlO is decreased. Exaggerated proFG protein 
expression is seen in Lamellar Ichthyosis and in BCIE. In X-
linked Ichthyosis. a disorder with a known lipid defect, proFG is 
normal. 
In Ichthyosis Vulgaris (IV) the granular layer is attenuated and 
keratohyalin granules (KHG) are abnormal. ProFG protein 
expression is markedly decreased. as shown by 
immunohistochemistry. immunoelectron microscopy. and 
Western blot. and proFG mRNA is decreased by in situ 
hybridization. Keratinocytes cultured from the epidermis of 
individuals with IV have decreased and abnormal appearing KHG 
and proFG protein and mRNA are barely detectable. whiie 
expression of Kl/KIO and loricrin, also associated with 
differentiation. is normal. 
Thus. the ichthyoses offer excellent models for understanding 
normal and pathologic epidermal differentiation. Abnormalities in 
proFG expression may offer clues to processes leading to these 
diseases. 
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EPIDERMOL YSIS BULLOSA SIMPLEX 
Epidermolysis bullosa simplex (EBS) is characterized by basal 
keratinocyte fragility and consequent formation of blisters that, 
unlike deeper blisters. heal without scarring. Nearly always it is 
inherited as an autosomal dominant disease with complete 
penetrance. 
During the past year we and several other groups have presented 
evidence indicating that this cellular fragility is due to mutations 
of genes encoding keratins that are expressed in the basal cells. 
This evidence is of three types. 
First, genetic linkage analysis has mapped the EBS gene in a 
half-dozen families to chromosomes 12q or 17q at the sites to 
which keratin genes have been mapped. Second, point mutations 
have been identified in four families . Three of these are in keratin 
14 and one is in keratin 5. The three families with the more severe 
Dowling-Meara SUbtype of EBS each have mutations in the 
conserved regions at the ends of the helical region; the one family 
with the Koebner subtype ofEBS has a Leu to Pro mutation in the 
middle of the helix. Third, transgenic mice with mutant human 
keratin genes express a phenotype similar to that of human EBS. 
These findings are among the early fruits of the application to 
human skin disease of the strategies and techniques of modem 
molecular genetics. Similar strategies have given evidence very 
recently that mutations of genes encoding keratins expressed in 
suprabasal keratinocytes underlie epidermolytic hyperkeratosis. 
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CLONING AND CHARACfERIZATION OF HUMAN 
TYPE VII COLLAGEN, THE CANDIDATE GENE IN THE 
DYSTROPHIC FORMS OF EPIDERMOLYSIS BULLOSA 
We recently demonstrated strong genetic linkage between the 
dystrophic forms of epidermolysis bullosa and the gene for human 
type VII collagen (COL 7 A I) on chromosome 3p21. To facilitate 
elucidation of the underlying mutations in these patients, we 
initiated extensive cloning of the corresponding gene and cDNA. 
In addition to our recently reponed cloning of a human type VII 
collagen cDNA (PNAS 88, 6931, 1991), we have screened human 
epidermal keratinocyte, placenta, WISH and skin fibroblast cDNA 
libraries for clones coding for the al(VlI) chain. At this point, we 
have elucidated 8.7 kb of the -9 kb mRNA. Deduced amino acid 
sequences revealed that the a 1 (VII) chain consists of a central 
collagenous domain characterized by repeating Gly-X-Y 
sequences which contain 22 imperfections, including a 39-amino 
acid non-collagenous "hinge" region. Sequences which encode the 
collagenous domain are flanked on the 5 ' side by >3.4 kb which 
encode a non-collagenous domain (NC-I), and on the 3' side by 
-0.5 kb which encode a non-collagenous NC-2 domain. Detailed 
characterization of NC-I revealed two high-frequency exonic 
polymorphisms which can be detected by PCR. The chimeric 
organization of NC-I revealed modules with homology to 
cartilage matrix protein (CMP), nine consecutive fibronectin type 
III domains, and the A domain of von Willebrand factor. The 
cysteine-rich NC-2 domain contained a region with similarity to a 
Kunitz module found in a3(VI) collagen, among other proteins . 
Recent characterization of the human gene for type VII collagen 
has revealed over 100 exons in a compact gene of -25 kb . 
Complete understanding of both the gene and cDNA for human 
type VII collagen will facilitate the identification of mutations in 
patients with the dystrophic forms of EB. 
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REGULA TION OF KERATIN GENE EXPRESSION BY 
HORMONES, VITAMINS AND GROWTH FACfORS 
Keratins, the principal structural proteins of epidermis, are also 
markers of keratinocyte function. K#I and K#lO mark the 
differentiated ' state, K#5 and K#14 the basal cells and K#6 and 
K#16 the activated cells. 
Among the most imponant biological and therapeutic 
modulators of keratinization are hormones and vitamins, such as 
retinoids and conicosteroids, which act through their nuclear 
receptors. To understand the effects of the receptors on gene 
expression in epidermis, we have prepared DNA constructs- in 
which promoters for the following keratin genes drive expression 
of the CAT reponer gene: K#3, K#5, K#6, K#10, K#14, K#16, 
K#17 and K#19. The constructs were co-transfected with vectors 
expressing nuclear receptors for retinoids, thyroid honnone, 
vitamin D3, estrogen and progesterone. 
Thyroid hormone uniformly inhibited keratin gene transcription. 
Retinoic acid induced keratins K#8 andK#18, but suppressed all 
others. Vitamin D3 had no direct effect, estrogen upregulated 
keratins K#8 and K#18, whereas progesterone regulated the basal 
layer specific keratins . The regulatory elements were identified 
using in vitro mutagenesis. Thus, hormones and vitamins 
superimpose quantitative regulation of the levels of keratin gene 
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rranscnpnon onto the qualitative, cell-type specific regulatory 
mechanisms. 
Because peptide growth factors affect keratinocyte function, we 
hypothesized that they also could regulate transcription of keratin 
genes. Keratin promoter constructs were rransfected into primary 
culrures of keratinocytes in the presence or absence of epidermal 
growth factor (EGF) . While transcription of all transfected 
promoters was increased in the presence of EGF, the 
K#6 and K#16 keratin promoters were specifically induced ten 
fold or more. We have localized the EGF-responsive elements to 
20 bp segments. We conclude that EGF alters the phenotype of 
keratinocytes by modifying the nuclear transcriptional machinery 
and inducing markers specific for activated keratinocytes. 
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TRANSLOCATION OF ACUTE 
LEUKEMIA GENERATES A 
ALTERED RETINOIC ACID 
Retinoic acid (RA) is a vitamin A derivative with major effects 
on differentiation and morphogenesis . Three retinoic acid 
receptors (RAR a,B,Y) that belong to the nuclear hormone 
receptor superfamily have been described. RARB was originally 
identified at an hepatitis B virus integration site in a 
hepatocarcinoma, suggesting a link between altered receptors and 
transformation . 
A specific translocation t(15,17) has been reponed in every 
patient with acute promyelocytic leukemia (APL) . Those patients 
achieve complete remissions when treated with oral all trans RA. 
This spectacular effect of the drug, together with the location of 
the RARa gene close to the breakpoint, suggested a (paradoxical) 
link between the two phenomenons. 
An APL-derived cell-line (NB4) was used to clone this 
translocation and show that it fuses RARa to a new gene: PML. 
PCR analysis demonstrate the presence of a PML/RARa fusion 
mRNA in every patient, indicating that this genetic alteration is an 
APL hallmark. 
The PML gene product displays a C3HC4 zinc finger motif 
common to several DNA-binding proteins and a leucine zipper; 
PML could encode a transcription factor. Hybrid cDNAs were 
isolated from the NB4 cell-line and shown to encode proteins 
containing the amino tenninus of PML (including the zinc fingers 
and leucine zipper) fused to the B or to E regions of RARa 
(containing the DNA and hormone binding domains) . This 
chimaeric transcription factor could interfere with either RAR or 
PML pathways. Transient expression studies show that 
PML/RARa is functionally altered when compared to RARa. 
Moreover PML/RARa can block RA-induced differentiation in 
some model systems. While interference with PML or RAR 
pathways could account for differentiation arrest and 
transformation, the spectacular effect of pharmacological doses of 
RA is poorly understood at present. 
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REGULATION OF COLLAGEN AND ELASTIN GENE 
EXPRESSION 
Collagen and elastic fibers are the major extracellular matrix 
components of the dermis, providing physiologic tensile 
propemes and resilience to the skin. Human skin contains at least 
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10 different collagen types which have a topographically 
companmentalized tissue distribution. Cloning of different 
collagen genes has provided probes to study the regulation of 
collagen gene expression. A variety of cytokines, growth factors 
and hormones can alter the expression of collagen genes at the 
transcriptional level. These effects are mediated by a variety of 
cellular factors, including AP-l, AP-2 and NF-l, which bind to 
the corresponding cis-elements in the promoter region of the 
collagen genes. This presentation discusses the regulation of 
collagen gene expression in the context of fibrotic skin diseases. 
Elastic fibers form a network which contributes to the elasticity 
of the skin. Characterization of the S'-flanking region of the 
elastin gene has identified several cis-regulatory elements which 
include regions of enhancers and silencer activity, as well as 
putative elements responsive to a variety of effector molecules. 
Recent development of transgenic mice which express a human 
elastin promoter/CAT reponer gene construct, has revealed that 
the elements for tissue specific expression of the elastin gene 
reside within 5.2 kb of the 5'-flanking DNA. This animal model 
provides a system to study the transcriptional regulation of elastin 
gene expression by trans-acting cytokines and pharmacologic 
agents. 
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PHOTOAGING: MECHANISMS OF RETINOIC ACID-
INDUCED IMPROVEMENT 
Roughness. brown spots. and wrinkles are features of 
photodamage improved by topical all-trans-retinoic acid (TRA). 
Possible correlates of improved rough skin (i.e .• smoother) due to 
TRA are compact and smooth stratum corneum (SC) and 
hygroscopic GAGs accumulating within epidennis and Sc. In 
treated skin. K6 and Kl3 are focally expressed and K5/14 and 
KIIlO are expressed with correct location and intensity. TGase K. 
involucrin. loricin. and filaggrin are expressed with normal 
intensity but extend deeper into the thickened epidennis. 
In photodamage. melanocytes are focally activated in brown 
spots. Such spots are lightened by TRA lasting> 6 months after 
RA is discontinued. Clinical lightening and light microscopic 
reduction of melanin are correlated (r = -.53, P < .00(1). By 
electron microscopy. melanosomes and melanosome complexes in 
kerarinocytes are markedly reduced. Thus. reduced melanin 
content is a probable cause of TRA's ability to lighten brown 
spots. 
Wrinkle improvement by TRA appears related to dermal 
changes. TRA causes accumulation of epidermal and dermal 
TGF-Bl. a cytokine known to stimulate accumulation of collagens 
I and VII, both of which. by ultrastructural criteria. are increased 
by TRA in photodamage. 
Improvement in photodamage is probably mediated by 
activation of RAR-y and RXR-a in epidermis and RAR-~ and 
RAR-y in dermis. The amount of free RA available to activate 
RARs and RXRs may be regulated by high affinity cellular RA 
binding protein (CRABP-ll) which is markedly increased by 
TRA. Free all-trans-RA is convened to 9 and 13-cis-RA. all 3 of 
which activate RARs whereas 9-cis-RA also activates RXR-a. 
Finally. TRA activity is greatly attenuated by major induction of 
cytochrome P-450 (type unkown). markedly reducing biological 
activity ofTRA in photodamaged skin. 
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THE STEROIDIRETINOID HORMONE RECEPTOR 
SUPERFAMILY AND RETINOID RESPONSE PATHWAYS 
The nuclear receptor superfamily represents one of the largest 
transcription factor families described today and includes 
receptors' for all known active steroid hormones and the vitamin 
D3. as well as receptors for retinoic acid. thyroid hormones and 
peroxisome proliferator substances. In addition. many "orphan" 
receptors have been identified for which specific ligands have not 
yet been defined. The steroid hormone receptors and the retinoic 
acid receptors represent the two largest subfamilies of the 
s~p~rfamily. each comprising six inctividual receptors encoded by 
distmct genes. This paper focussed mainly on the mechanisms of 
action of retinoic acid receptors. Although it was originally 
assumed that all nuclear receptors function via the same basic 
mechanisms. it has become apparent now that the retinoic acid 
receptors operate quite differently tllan originally assumed. One of 
the RA receptor types, the retinoid X receptors (RXR) is already 
fC?un~ in insects (in contrast to the other mammalian ligand 
bm.di.ng receptors) and plays a central role in regulating the 
acnvlty of several receptors, including thyroid hormone receptors 
~s). vitamin D3 receptors (VDR) and peroxisome proliferator 
acnvated receptors (PPAR). Contrary to earlier assumptions. the 
clasSIcal RA receptors (RARs) do not bind effectively to DNA 
and require auxiliary proteins for effective DNA interaction. The 
RXRs are such auxiliary receptors for RARs. dramatically 
increasing the affinity of RARs for specific DNA sites by 
heterodimer formation. Similarly RXRs function as auxiliary 
'receptors for TRs. VDRs and PPARs. Thus, RXRs control a 
number of hormonal pathways through heteroctimer formation . 
While RARs are acti.vated by all-trans as well as 9-cis-RA. it was 
found that RXRs bmd only 9-cis-RA with high affinity. This 
raised the possibility that the 9-cis-RA isomer could control 
specific response pathways. We have now obtained evidence that 
in the presence of 9-cis-RA. RXRs can form homodimers that 
activate specific genes. In contrast RARs do not 
form homodimers in the presence of 9-cis-RA (or all-trans-RA). 
Thus. RXRs have a central role in regulating distinct retinoid 
pathways through heterodimer formation with RAR and other 
hormonal receptors. while in the presence of 9-cis-RA. they can 
function independently by forming homodimers. The elucidation 
of the different retinoid signalling pathways should allow a more 
rational design of effective retinoid therapeutics while undesired 
side effects may be preventable. 
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THE EFFICACY AND TOLERABILITY OF TOPICAL 
CALCIPOTRIOL IN PSORIASIS VULGARIS 
Calcipotriol is a new synthetic vitamin D analogue developed 
for the topical treatment of psoriasis. Similar to the natural 
bioactive form of vitamin D3. 1.25-dihydroxyvitamin D3. 
calcipotriol binds to the intracellular vitamin D receptor and 
induces a number of biological activities such as inhibition of cell 
proliferation. induction of cell differentiation and modulation of T 
lymphocyte activities. In contrast calcipotriol is 100-200 times 
less potent in causing increased serum and urine calcium levels. 
This pharmacological profile makes calcipotriol an ideal 
candidate for the topical treatment of psoriasis. In dose-finding 
studies a concentration of 50 mikrogram/gram has been found to 
be optimal for the treatment of psoriasis vulgaris. Furthermore. 
treatment with calcipotriol ointment 50 mikgrogramlgram is 
slightly more effective than the treatment with betamethasone 
valerate ointment 0.1 % and short-contract dithranol therapy. 
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After stopping calcipotriol treatment, psoriasis may recur. If the 
treatment is maintained, it is possible to maintain the induced 
improvement. Furthermore, addition of UVB-light therapy can 
increase the anti-psoriatic effect induced by calcipotriol. 
Treatment with calcipotriol ointment can cause skin irritation, 
particularly in the face. Therefore, the face should not be treated. 
If used in amounts up to 100 gram per week, no changes were 
observed in any of the biochemical markers of bone and calcium 
metabolism. It is concluded that calcipotriol is an effective and 
well-tolerated drug for the topical treatment of psoriasis. It should 
be considered one of the first line drugs for the treatment of this 
disease. 
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France. 
RETINOIC ACID RESPONSIVE ELEMENT IN THE LONG 
CONTROL REGION OF HUMAN PAPILLOMA VIRUS 
We previously reponed (1) that addition of retinoic acid (RA) to 
normal human keratinocytes grown in medium containing 
delipidized serum resulted in the activation of transcription from 
the construct pH 18CA T. containing the HPV 18 long control 
region (HPV 18-LCR) cloned upstream of the CAT reponer gene. 
We show here that in HeLa cells, the pH 18CA T construct is 
transcriptionally down-regulated by RA when either RARa., 
RAR(3 or RARyl are cotran sfec ted. We have localized a possible 
cis-acting RA-responsive element in the HPVI8-E6 promoter 
region . Direct interaction of RARs with this sequence was 
demonstrated by gel-shift experiments. Moreover, this sequence 
confers RA-responsiveness to the herpes virus thymidine kinase 
(TK) promoter. This sequence contains the direct repeat motif 
AGTTCATGTTAAGGGTA similar to that identified as RA-
responsive elements (RAREs) in the promoter region of the 
RAR(3 gene and other RA-responsive genes. 
(1 ): Bernard, B.A. . Magnaldo, T.. Lenoir, M.e., Bailly, e. and 
Darmon, M. (1990) Modulation of papillomavirus transcription by 
viral transeffectors and retinoids. In: Papillomaviruses. Wiloy-
Liss. Inc .. New York. pp. 481-490. 
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Berghard", Karolinska Institute, Department of Medical Nutrition 
and ·Center for Biotechnology, Huddinge Hospital F-60, Novum, 
Huddinge, Sweden. 
THE DIOXIN RECEPTOR: A LIGAND·ACTIV ATED 
GENE REGULATORY PROTEIN 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin) induces 
transcription of a number of genes encoding drug metabolizing 
enzymes such as glutathione S-transferase Ya and cytochrome P-
4501A 1. Signal transduction by dioxin is mediated by the 
intracellular dioxin receptor which, in its ligand-activated state, 
interacts with dioxin-responsive positive DNA control elements 
near the regulated promoters. The inactive receptor form is 
associated with an inhibitory protein (hsp90). Hsp90 plays dual 
roles in the modulation of functional receptor activites: it is 
critical for a dioxin-responsive conformation in that it is required 
for formation of a stable ligand-receptor complex; and it inhibits 
the DNA-binding activity of the receptor. Moreover, receptor 
activity appears to be modulated by protein kinase Codependent 
phosphorylation. and by heterodimerization of the 100 kD dioxin-
binding subunit with an 85 kD non ligand-binding protein which 
may be related to the recently cloned helix-loop-helix factor, Arnt, 
which contrOls nuclear translocation of the dioxin receptor. 
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CLONING OF THE HUMAN CELLULAR RETINOIC 
ACID·BINDING PROTEIN II (CRABP.II) GENE: TRANS· 
CRIPTIONAL REGULATION BY RETINOIC ACID 
The human CRABP-I and CRABP-II cDNAs have recently been 
cloned from human skin. Furthermore, retinoic acid (RA) causes a 
striking induction of CRABP-Il but not CRABP-I mRNA in skin 
in vivo and in skin fibroblasts in vitro. To further dissect the 
mechanism for retinoic acid induction of CRABP-ll, we cloned 
the human gene. A human genomic library was screened using the 
CRABP-Il cDNA as a probe. A clone approximately 16.5 kb in 
size was isolated. and by restriction mapping and sequencing was 
found to contain the entire CRABP-Il gene. The gene is 
approximately 6 kb in size and divided into 4 exons. The upstream 
region of the gene contains a TAT A box and potential binding 
sites for SPl, AP2 and Krox-24, as well as a direct repeat with 
homology to the retinoic acid responsive element (RARE) found 
in the RAR-P2 gene. 
The CRAPB-II mRNA was rapidly induced within 2-6 h in 
cultured human skin fibroblasts by retinoic acid, reaching a 
plateau after 6 h of treatment. However. removal of retinoic acid 
from the medium after 12 h caused a sharp decline of CRABP-II 
mRNA levels. The rapid increase of CRABP-Il message was 
mainly due to an increased rate of transcription as determined by 
nuclear run-on experiments. Increased transcription could be 
detected as early as 1 h after addition of RA, peaked at 2 h and 
returned to basal levels within 6 h. On-going protein synthesis was 
required for this transient increase of transcription, since the 
induction was blocked by cycloheximide. These data suggest that 
the human CRABP-II gene is transcriptionally regulated by a 
newly synthesized regulatory protein. However, once CRABP-Il 
mRNA is produced, message stabilization may be a means by 
which elevated CRABP-I1 mRNA is maintained. 
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SYNTHETIC RETINOIDS • RECEPTOR SELECTIVITY 
AND BIOLOGICAL ACTIVITY. 
Retinoids constitute one of the most promising groups of drugs 
in dermatology today. although they exhibit a series of toxic 
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effects. The recent discovery of three distinct nuclear retinoic acid 
receptors (RARa, RAR~, RARy) offers an appealing rationale 
for an approach to improve the benefit/risk ratio by the design of 
receptor selective compounds. With this objective in mind we 
evaluated a series of derivatives of 6-aryl-~-naphthoic acid, stable 
retinoic acid analogues, for (i) their in vitro affinity to 
recombinant human receptors RARex, RAR~, and RARy, (ii) 
their transactivating potential in HeLa cells cotransfected with the 
appropriate RAR expression vectors and a TRE3-tk-CAT reponer 
plasmid, (iii) the induction of plasminogen activator in the murine 
teratocarcinoma cell line F9, and (iv) the repression of plasma 
membrane-associated transglutaminase in cultured human 
keratinocytes . 
We found that variation of substituents on the aryl ring have 
little effect on binding to RARa but that opening of the naphthoic 
acid ring, which results in benzoic acid derivatives, improves the 
affinity to RARa. Reduced lipophilicity in the central region of 
the molecule, and panicularly the introduction of functions with 
hydrogen bonding propenies potentiates RARa binding and, 
when combined with cenain aryl substituents, results in RARex 
selectivity. On the other hand, binding to RAR~ and RARy is 
strongly influenced by para (but not meta)-substituents of the aryl 
ring: hydrogen bond acceptors in this position increase RAR~ 
selectivity, whilst hydrogen bond donors promote RARy 
selectivity . 
Transcriptional activation is more sensitive than in vitro 
binding, but results essentially in the same receptor selectivity 
profile, whereas the correlation between receptor selectivity and 
biological activity in genetically 'non-manipulated' cellular 
systems (F9, keratinocytes) is poor. Nevenheless, preliminary 
results obtained with a reconstructed skin model indicate that 
receptor selective retinoids possess discriminating properties, 
which influence epidermal morphology and differentiation. 
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VIRAL VECTORS FOR GENE THERAPY 
More than twenty families of viruses are known to infect animal 
and human cells. Each has evolved a unique strategy for selecting 
and colonizing cells where viral multiplication can occur. The 
genetic material of viruses can be manipulated as cloned genes 
and cDNA and a wealth of knowledge has accumulated 
concerning the molecular mechanisms of viruses growth and 
interaction with the infected cell. As a consequence, it is possible 
in many cases to design and assemble recombinant viruses, where 
foreign genes are insened into the viral genome and transponed to 
the cell through the infectious process. The major applications of 
viral vectors are : a) the efficient transfer and expression of genes 
in tissue culture, b) the design of vaccines using recombinant 
atten uated viruses displaying antigenic epitopes from various 
pathogens, and c) the in vivo delivery of therapeutic genes. 
The later application requires a viral vector able to efficiently 
transfer its genetic material to a variety of cell types, without 
affecting their physiological propenies. Transferred genes must be 
stably maintained into the target cell, either as an integrated 
structure linked to the genome or as an episome. The vector 
design must allow for the sustained expression of the implanted 
therapeutic gene over long periods of time. Finally, the potential 
risks associated with the vector system (oncogenicity, viral 
disease) must be documented. 
Three human DNA viruses (Herpes Simplex Virus, Adenovirus 
and Adeno-Associated Virus) and a murine retrovirus (Mouse 
Leukemia Virus) are currently studied as vectors for gene therapy. 
Until now, only retroviral vectors have been used in clinical trials. 
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ALL TRANS RETINOIC ACID: A T ARGETTING DRUG 
FOR THE DIFFERENTIATION OF ACUTE 
PROMYELOCYTIC LEUKEMIA 
All-trans retinoic acid (A TRA) is able to specifically 
differentiate acute promyelocytic leukemic cells (APL) in shon 
term culture (Chomienne et al., Blood 1990). Patients with APL 
achieved complete remission within 1 to 3 months by a 
progressive maturation of leukemic cells (Huang et al., Blood 
1988; Degos et al., Lancet 1990). The advantages of this 
differentiation therapy is the rapid disappearance of the bleeding 
disorder and the absence of aplastic phase avoiding the early 
deaths occuring in 15 to 30 % of patients with conventional 
chemotherapy. However, relapses occur when A TRA alone is 
maintained. For this reason, a chemotherapy is added after 
complete remission obtained by ATRA. A pilot study on 27 
patients was proposed with the sequential combination of A TRA 
and chemotherapy leading to 70 % of actuarial event free survival 
(83 % actuarial disease free surviVal) at 18 months . A European 
trial randomizes conventional therapy to the sequential ATRA-
chemotherapy protocol (70 patients included). 
Retinoic acid receptor (RARa) is rearranged by the specific 
translocation t(15;17) of APL (de The et al., Nature 1990); a PCR 
technique was developped (Castaigne et al., Blood, in press) in 
order to ensure the diagnosis and to follow the minimal residual 
disease. Transfection experiments of the chimaeric gene in 
granulocytic cells (HL60) specifically inhibits the in vitro 
differentiation induced by retinoic acid (Farzinet et a!., Nature, in 
press). The arrest of maturation of granulocytic lineage could be 
one of the major step of the leukemogenesis. A TRA is able to 
reven the arrest of maturation may be through a modulation of the 
expression (increased) of the normal allele of RAR (Chomienne et 
al., l.Clin.Oncol. 1991), which could overpass the impairment 
induced by the chimaeric protein on target responsive elements. 
One of the steps of the repair is the modulation of programmed 
cell death (PCD). BcI-2, a gene involved in the PCD, is modulated 
in in vitro studies, arguing for the engagement of the cell in the 
natural death (Chomienne et a!., in preparation). The beneficial 
effect of "differentiation therapy" probably is due to the induction 
of the natural death of the malignant cell. 
16 
R.M. Lavker, C. Wilson, G. Cotsarelis and T.-T. Sun*, 
University of Pennsylvania, School of Medicine, Department of 
Dermatology, Philadelphia and *New York University Medical 
Center, Department of Dermatology and Pharmacology, New 
York, USA. 
THE TELOGEN FOLLICLE: A MODEL FOR STUDYING 
HAIR GROWTH 
The hair follicle is an epidermal derivative which independently 
undergoes a regular cycle of growth (anagen), involution 
(catagen) and rest (telogen). During the growing phase a new 
outer root sheath is formed and the matrix keratinocytes located in 
the bulb area proliferate rapidly. At the end of anagen, matrix 
keratinocytes abruptly cease proliferating and these cells necrose 
so that the lower follicle involutes. During this time the 
mesenchymal cells of the follicular papilla become condensed and 
are positioned at the bonom of the permanent portion of the hair 
follicle, and remains there during the telogen stage. Eventually a 
new growing phase occurs, and the cycle is repeated. 
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We have found that a subpopulation of relatively primitive. 
slow-cycling cells. which can be stimulated to proliferate in 
response to wounding (features consistent with stem cells). are 
located in the upper portion of the follicle in a region known as 
the "bulge". We proposed that these hair follicle stem cells. upon 
division. would give rise to a population of transient-amplifying 
(TA) cells which would differentiate into outer root sheath and 
matrix keratinocytes (Cell 61. 1329. 1990). This theory is in 
contrast to the widely-held belief that the germinative center of 
the hair follicle is in the anagen bulb. and that the follicular stem 
cells are located in the matrix kerarinocytes. 
A central tenant of our hypothesis is that at the beginning of 
anagen. the normally slow-cycling stem cells of the bulge area 
would be "activated" by the abutting follicular papilla cells and 
proliferate giving rise to a population of TA cells. which form the 
new down growth. Funhermore. we postulated that the bulge cells 
would return to their quiescent state during mid- to full-anagen . 
Using morphological and cell kinetic techniques we provide 
experimental evidence to show that in early anagen mouse skin. 
bulge cells indeed undergo transient proliferation during early 
anagen. giving rise to the highly proliferative matrix keratinocytes 
of the new hair follicle. We also repon that during the resting 
phase. the bulge cells can be stimulated to proliferate in response 
to anagen follicle . These observations lend strong suppon to our 
bulge activation hypothesis and suppon the suggestion that bulge 
cells are the origin of the lower follicle in anagen. They also 
establish the usefulness of the resting phase of the hair cycle as a 
model to study the effects of various growth stimuli on hair 
follicle formation . 
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RETINOID RECEPTOR-REQUIRED EXPRESSION OF 
TISSUE TRANSGLUT AMlNASE 
The expression of Tissue Transglutaminase (TTg) is under 
complex control. operating at a very low level in most 
undiffe~entiated and proliferating cells and increasing 
dramatically as cells enter into states of terminal differentiation, 
senescence and death. Previous studies from our laboratory have 
identified retinoids as acute, specific and direct regulators of TTg 
gene expression. In the studies to be reponed here we have used a 
combination of pharmacologic and transfection approaches to 
establish the role of specific retinoid receptors in the induction of 
the enzyme. Our results demonstrate that the expression of this 
enzyme is regulated both by retinoid acid receptors (RAR's) and 
r~cept?rs for 9-cis-re~n~ic acid (RXR's). To investigate the 
blOloglcal role of reunOid-regulated TTg expression we have 
com~ared the localization of the enzyme with the expression of 
specific RAR's in developing chick limb buds. The results 
demonstrated TTg expression co-localized to sites with both 
RAR-~ . or RAR-y expression. These studies suggest that the 
expresslOn of TTg can be linked to the activation of multiRle 
retinoid receptors. . 
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ANTISENSE APPROACHES IN DERMATOLOGY 
Antisense technology, based on the design of antisense 
compounds complementary to an RNA or a DNA sequence 
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critical to a disease process. offers the potential to revolutionize 
the pharmaceutical industry. Antisense represents a rational drug 
design approach, in which the genetic code of the disease dictates 
the structure of the antisense drug. 
A therapeutic approach targeted to mRNA by means of 
antisense oligonucleotides or ribozymes is a wide ranging 
technology. Once established, this technology could be potentially 
applied to any disease in which the expression of a known 
responsible gene is involved. However, the development of 
effective delivery methods will be of vital imponance to the 
market growth for antisense molecules. 
It is obvious that topical delivery of dermatological drugs allows 
to circumvent most of the difficulties of targeted delivery. For 
antisense oligonucleotides and ribozymes, topical applications for 
dermatological diseases is a preferred way for an easy and 
targeted delivery. Apan from the viral infections such as Herpes 
or Papilloma, many other dermatological diseases including 
inflammatory diseases as atopical dermatitis or lUpus, diseases of 
the keratinization process such as ichthyosis and psoriasis, 
neoplasic diseases such as melanoma or cutaneous T lymphoma, 
represent potential targets for an antisense therapeutic approach. 
The dermatological drugs and the cosmetic market is wide and 
is cenainly one of the most promising for the use of antisense 
drugs. 
Dermatological pathologies. as well as ex-vivo treatments of 
hematological diseases, will be one of the first applications of 
antisense molecules. Current investigations, clinical trials in 
progress, patent and regulatory issues will be discussed. 
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MCT, MCC and MCTC IN 
DERMATITIS AND LICHEN 
Human skin mast cells contain a number of preformed 
mediators which are released after immunological and non-
immunological stimuli. Among them are two serine proteases. 
tryptase and chymase. which represent over 50 % of the total 
protein of the mast cell granules. Due to the proteolytic effect on 
protein substrates imponant in the elicitation of an inflammatory 
response (Ill. VIP). the release of these proteases may playa role 
In physiological and pathophysiological conditions. 
We investigated the distribution of tryptase-(MCT). chymase-
(MCC) and tryptase/chymase-containing (MCTc) mast cells in 
involved skin from psoriasis. atopic dermatitis and lichen planus 
by enzymhistochemical techniques using specific substrates for 
tryptase and chymase. 
In fresh frozen biopsies of involved skin from psoriasis (9113) 
and hchen planus (6/6). we observed a high increase of MCT in 
s?,atum papillare but not in the stratum reticulare. In psoriasis and 
hchen planus the MCT were particularly prominent beneath the 
epidermis in close juxtaposition to the stratum basale. In two cases 
of lichen planus the MCT could be identified in the stratum 
basale. 
In atopic dermatitis (8/8) MCT were also increased near the 
epidermal .boundary and in addition. around the skin appendages 
such as haIr folhcles. blood vessels and sweat glands. While MCC 
were occasionally identified in involved skin from psoriasis and 
atopic dermatitis. the MCTc were found in small numbers in the 
stratum papillare and particularly in the stratum reticulare. 
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Our results show not only increased numbers of mast cells in 
involved compared to uninvolved skin but a shift to MCT which 
are extremely rare in normal skin. These MCT may be the result 
of inflammatory events and may p~ay a role in the initiation and 
maintenance of inflammatory diseases. Tryptase. the mam 
protease in these mast cells. may be involved. 
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ORAL MET APLASIA OF ADULT HUMAN EPIDERMAL 
KERA TINOCYTES GROWN IN VITRO IN THE 
PRESENCE OF RETINOIC ACID 
A striking effect of retinoic acid (RA) is its abi~ity to alter cell 
fate during development. The mucous metaplaSia produced by 
trearing chick embryo skin with RA is a classical example of thiS 
property. It has so far b~en impossible to reproduce with adult 
keratinocytes grown In VitrO such a metaplaSia. although RA has 
been shown to block terminal epidermal differentiation, to induce 
an increased synthesis of mucopolysaccharides, and to induce 
markers of non-keratinized epithelia such as K 19 and K 13 
keratins . When adult human keratinocytes are grown on dermal 
lattices at the surface of the culture medium. they are able to form 
a normal keratinized epidermis. But, when excess RA is added. to 
the culture medium. a stratified non-keratinized (parakeratotic) 
epithelium is formed . The distribution . of . tissue- and 
differentiation-stage specific markers In thiS epithelium shows that 
it has close resemblance with the oral epitheliUm. Moreover, when 
this tissue is transferred into a normal medium (no RA added), a 
new epithelium is formed beneath the "ol~" one at the expe~s~ of 
basal cells. and this epithelium has an epidermal onhokeraomzed 
phenotype, whereas the "old" epitheliu":l .~mains unchanged. 
These observations show that the reverSibility of the changes 
produced by RA are only apparent, .since the metaplastic tiss~e 
remains unchanged and the new ussue IS denved from soli 
uncommilted cells. Altogether, our studies suggest that adult 
keratinocytes treated in vitro by RA. although unable to trans~orm 
into mucous cells. undergo a metaplaSia InIO a wet stratified 
epithelium closel y resembling oral epithelia. 
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CORRECTION OF THE DEFECTIVE FIBRONECTIN 
E XTRACELLULAR MATRIX OF EHLERS-DANLOS 
SY NDROME SKIN FIBROBLASTS BY 
DEXAMETHASONE TREATMENT 
The Ehlers-Danlos syndrome (EDS) constitutes a heterogenous 
group of heritable connective tissue disorders which ca.n . be 
di stinguished in II different types on the baSIS of climcal 
manifestations and pattern of inheritance. 
We report that in vitro cultured skin fibroblasts from EDS type I 
to VIII lack an organized fibronectin (FN)-containing extracellular 
matrix (ECM); this defect can be corrected by cultivation of EDS 
cells over a feeder of control fibroblasts or by the addition into the 
culture media of FN purified from control fibroblasts (cellular FN: 
cFN) but not of FN obtained from plasma (plasma FN: pFN). cFN 
differs from pFN for the presence of higher levels of isotypes 
containing a region undergoing alternative splicing (i.e. EDA). 
Quantitative in situ hybridization shows that EDS cells mature 
reduced amount of EDA + FN mRNA if compared with control 
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fibroblasts, thus suggesting a relationship between alternative 
splicing processes and the FN-ECM defect in EDS cells. 
In vitro cultured skin fibroblasts derived from EDS type I to VII 
treated with dexamethasone (Dex) - a synthetic glucocorticoid 
known to stimulate the biosynthesis of FN in in vitro cultured 
cells - organize a FN-containing ECM. The ECM correction is 
related to the induction of FN mRNA in all cell types. These data 
suggest the possible use of Dex in the therapy of the most severe 
EDS cases. 
Work supported by CNR PF "Genetic Engineering" and 
"Biotechnology and Bioinstrumentation", AIRC and Concerted 
Action on HerD 1990·92. 
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SPERMIDINE-MEDIATED CROSS-LINKING IN 
MAMMALIAN EPIDERMIS: A POTENTIAL MARKER 
FOR KERA TINOCYTE DIFFERENTIATION 
The N l ,N8-bis(y-glutamyl)spermidine cross-link occurs as a 
post-translational modification in several structural proteins. 
These cross-links are formed by calcium-required 
transglurarninases, which catalyze the formation of a covalent 
bond between the carboxyl group of the 'Y-carbon of peptide-
bound glutamine residues and the primary amine groups of 
spermidine. The glutamyl-spermidine cross-link is resistant to 
enzymic and chemical attack and it is presumed that its biological 
role in the case of epidermis is a structural one. Recently this 
cross-link was found in proteins of the cornified envelope of 
cultured human epidermal keratinocytes. Significantly higher than 
normal frequency of this cross-link was observed in envelopes 
from afflicted areas of psoriatic patients. These chemically-
resistant protein envelopes develop beneath the plasma membrane 
of cells in the stratum corneum during epidermal differentiation. 
Spermidine cross-link was located in the fraction insoluble to 
thiol-SDS extraction. The polymenzauon pathway of proteins by 
spermidine proceeds by two steps. Initially, a primary amino 
group reacts with a y-glurarnyl site of a protein, leading to the 
formation of a mono-(y-glurarnyl)spermidine. Finally, the 
remaining primary amine group is cross-linked to another y-
glurarnyl site. This mechanism suggests that soluble acceptor 
substrates are present in the cytoplasm of the living cell layers of 
the epidermis. It was envisaged that during the course of 
epidermal differentiation, these proteins become increasingly 
cross-linked because of epidermal transglutaminase activity, 
resulting in a polymer which could only be solubilized by 
treatments that cleaved peptide bonds. Analysis of spermidine 
cross-links in malignant or virally transformed human 
keratinocytes shows a severe reduction of the level of this cross-
link. Additionally studies are in progress to evaluate the 
usefulness of this post-translational modificarion of proteins as a 
marker in staging and biochemically characterizing abnormally 
keratinizing epidermal cell lines and epidermis. 
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13-CIS-RETINOIC ACID IN REFRACTORY CUTANEOUS 
KI-I LYMPHOMA 
Increasing interest has recently been shown as regards .the 
therapeutic effects of systemic retinoids on dermatological 
malignancies following successful results in T-cell erythroderma 
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and mycosis fungoides. A report on the response to l3-cis-
Retinoic Acid in refractory Ki-I lymphoma is given relating to a 
34-year-old male patient in whom papular and nodular lesions 
which had been present for 2 years continued to relapse despite a 
variety of treatments (Re-PUV A, systemic steroids, electron beam 
therapy). The cutaneous necrotic nodules recurred after a few 
weeks partial remission with each therapy. Histopathological 
findings from the three skin biopsies taken revealed an unchanged 
pattern of malignant T-cell lymphoma with features common to 
pagetoid reticulosis, large anaplastic T-cell lymphoma and 
nodular mycosis fungoides. Immunophenotyping with a panel of 
T-cell and B-cell specific monoclonal antibodies gave a pattern of 
Ki-I positive cutaneous T -large cell lymphoma. Complete 
remission with the disappearance of the nodules was obtained for 
a period of 10 weeks wi th a dail y regimen of 60 milligrams of oral 
l3-cis Retinoic Acid (1 mglkg/day) followed by sudden and total 
relapse during the therapy. Contrary to reports by other authors, 
the effect of 13-cis-Retinoic Acid was only temporary and, 
although thi s drug should be considered in the treatment of 
cutaneous Ki-I lymphoma, further reports are clearly required 
before any picture can be built up of the appropriateness of this 
therapy. 
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A NOVEL IN VITRO MODEL FOR THE STUDY OF 
HUMAN KERA TINOCYTEILEUCOCYTE INTER-
ACTIONS UNDER AUTOLOGOUS CONDITIONS 
Keratinocyte!leucocyte interactions have become an area of 
intense investigations in the last decade. However, only few 
convenient in vitro models are available at this time. Thus, we 
designed a novel in vitro system for autologous human 
keratinocyte!leucocyte co-culture. Non invasive epidermal cell 
sampling was achieved by using outer root sheath cells from hair 
follicles : after one passage, pure keratinocyte cultures (no 
Langerhans cells or melanocytes) were obtained. Co-culture 
experiments were performed on a Transwell system : 
kerannocytes were grown on the porous cupula, and then laid onto 
wells containing leucocytes. Alternatively, leukocytes could be 
added to the cupula when contact interactions beTWeen the two 
cell types have to be investigated. 
Using this system, we demonstrated that PHA-P activated T 
lymphocytes (with 10% monocytes) in the lower compartment 
induced ICAM-I and ID..A-DR expression, and inhibited methyl-
3H-thymidine incorporation in normal human autologous 
keratinocytes cultured on the cupula. These changes were 
mediated by soluble factors (no cell contacts beTWeen 
keratinocytes and leucocytes) and required lymphocyte activation. 
This is the first direct in vitro evidence for leucocyte-induced 
!CAM-l a~d HLA-DR expression on keratinocytes. This system 
~s a potential tool to study keratinocyte!leucocyte interactions: it 
IS easy to perform, keratinocyte and leukocyte responses can be 
assessed separ~tely (proliferation , surface antigen expression), 
expenments Wlthm a given donor can easily be reproduced, and 
thiS ~nodel lends itself to a vast range of different experimental 
condmons. 
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NEW RETINOIDS WITH SELECTIVITY FOR BETA 
AND/OR GAMMA NUCLEAR RETINOIC ACID 
RECEPTORS 
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Retinoic Acid (RA) plays a fundamental role in cellular 
proliferation and differentiation. RA and a few synthetic 
analogues (retinoids) are currently used for the treatment of 
certain dermatological disorders, mainly acne and psoriasis. The 
discovery of several nuclear receptors for RA has engendered 
hopes that analogues with selective affinity for one of these 
receptors will possess a more tissue-specific activity than RA and 
therefore could be associated with reduced side effects. In 
previous work we have reported that biological activity of 
retinoids in F9 cells correlates with their affinity for nuclear 
receptors present in whole cells. 
Here we repon a further characterization of the family of 
compounds related to the new dermatological agent 
ADAPALENE (CD 271)*. Briefly, we have carried out 
structure/activity and structure/affinity studies of a series of 
retino-naphthoic acids by systematic variation of substituent 
groups on the aromatic ring which corresponds to the lipophilic 
region of RA. The binding affinities for isolated receptors and the 
in vitro biological potencies (differentiation of murine F9 
teratocarcinoma cells) of all compounds are reported here and 
related to their molecular structures. Compounds exhibiting 
selectivity for either the Beta and/or Gamma retinoic acid receptor 
were identified (B. Martin et al., Skin Pharmacol, 1992,5,57-65). 
Relationships between in vitro differentiating potencies and 
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THE EFFECT OF COMBINED TREATMENT WITH 
PREDNISONE AND CYCLOSPORINE IN PEMPHIGUS 
VULGARIS - A COMPARATIVE OPEN STUDY 
Sixt.een hospitalized pemphigus vulgaris patients received 
combmed treatment with cyclosporine and prednisone for 12 
months. Cyclosporine was given orally twice daily, with the initial 
dose of 5 mglkg/day adjusted to obtain plasma levels of 100-150 
ngIL. Prednisone was given at an initial dose of 60-80 mg/day, 
with tapering in accordance with clinical improvement Fifteen 
pemphigus patients receiving prednisone alone at an initial dose of 12q mg/day served as a comparative group. Thirteen of the 16 
p~tlents completed one year of follow-up. All 16 patients achieved 
chnical remission within 25 days or less. New blister formation 
ceased after a mean of 11.1 days of onset of treatment in the 
combined treatment group versus 20.5 days in the comparative 
group (p=O.OO4). Hospital stay was shoner in the combined 
treatment group (mean, 32.6 days) than in the comparative group 
(mean, 50.7 days; p=O.(03). The mean total accumulative 
pre~isone dosag~ during hospitalization and follow-up was 8853 
mg m t~e combmed treatment group and 12,977 mg in the 
comparative group (p=O.008). The most common side-effect in 
the. 16 patients receiving combined treatment was fatigue (10 
paoents), .followed by muscle and joint pain (9 patients), and 
hypertenSIOn and hypertrOphic gingivitis (6 patients each). In view 
of our result~ it seems that combined use of prednisone and 
cyclosponne IS more effecove than prednisone alone for the 
~tment of ~emphigus. In addition, this preliminary study 
mdicates ~ corticosteroid-sparing effect of cyclosporine. A large 
double-blind, randomized study is needed to confirm these 
findings. 
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ALTERED IL-! and IL-6 RELEASE BY PSORIATIC 
E PIDERMAL CELLS AND ITS RESTORA TION BY 
TOPICAL CORTICOSTEROIDS 
Dysregulation of IL-I and increased levels of IL-6 have been 
observed in psoriatic lesions. However, the data on these 
cytokines are often seemingly contradictory due to the use of 
different types of skin samples and single assays for their 
detection. We determined the basal levels of immunoreactive as 
well as biologically active IL-I and IL-6 released by epidermal 
cell (EC) suspensions of psoriatic and normal healthy skin. 
Freshly isolated, vital EC were cultured in low ea2+ basal 
medi urn (106 cells/ml) for 24 hours after which supernatants were 
collected. The levels of both cytokines were measured in all 
samples using ELISA's and the DIO and B9 bio-assays in parallel. 
The results showed that IL-ll3 immunoreactivity was increased 
by more than 10 to 20 fold in 80 % of the psoriatic EC 
supernatants whereas the bioactivity was reduced. These findings 
are in agreement with reponed data on IL-I in skin homogenates 
and point to a possible involvement of an inhibitor for IL-l. The 
ELISA and bio-assay results for IL-6 correlated well. Both tests 
showed that IL-6 production by freshly isolated EC was elevated 
in 50 % of the patients. In vivo treatment for six weeks with 
topical corticosteroids restored the altered cytokine profiles. The 
abnormal patterns of IL-I ~ and IL-6 release by unstimulated 
psoriatic EC stress their primary involvement in psoriasis. 
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A M ODEL OF CHRONIC ECZEMA IN THE HAIRLESS 
M OUSE 
M ost of the animal models of contact eczema rrurruc acute 
human pathology. In the present study, it is demonstrated that 
once daily topical applications of low dose of oxazolone (0.3%) 
on the dorsal skin of hairless mice induce an acute contact eczema 
which develops into a chronic state. After one week of treatment, 
the animals appeared to be sensitized to the hapten. Macroscopical 
and histological studies and measurements made with the MOP-
Videoplan system at different stages during the treatment, ranging 
from one week to II weeks, showed that during the second week, 
an acute lesion develops which is characterised by extensive 
desquamation, erythema, spongiotic vesicles, and increase of 
epidermal and dermal thickness. At later stages, this acute lesion 
changes to a chronic state characterized by a decrease in 
desquamation and spongiotic vesicles, maintenance of erythema, 
hyperplasia, and dermal oedema, and presence of d=a1 
infiltrates. Numeration of dermal mast cells indicated that their 
number began to increase during the third week and continued to 
increase constantly during the following weeks becoming 5 times 
higher than control at 11 weeks. Topical treatment with 2 NSAIDs 
(parfenac and piroxicam) or 3 steroids (hydrocortisone, 
Betamethasone-17-valerate (BMV), or dermoval) of the acute 
lesion, or of the chronic lesion, indicated that only the two steroids 
(BMV, or dermoval) -were active on both types of established 
lesions. They reduced hyperplasia. dermal oedema and dermal 
infiltrates. In conclusion, the present data describe a model of 
chronic eczema in mouse which demonstrates numerous 
similarities with the human pathology, such as the mode of 
induction, numerous morphological characteristics, and its 
pharmacological response. As the mode of action of hapten, such 
as oxazolone is to form a complex with an epidermal protein and 
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to induce an immune mediated response to this complex, it is 
proposed that such a model could also serve to mimic cenain 
aspects of auto-immune diseases, such as atopic dermatitis or 
psoriasis. 
PII 
E. Demirpence"' , M. Pons "' and D. Gagne"' ,**; *INSERM U 58 
and **Faculte de Pharmacie, Laboratoire de Biochimie, 
Montpellier, France. 
USE OF BIOLUMINESCENT CELLULAR MODELS FOR 
STUDYING INTERACTIONS BETWEEN ESTROGENIC 
AND RETINOID ACTIVITIES 
The antiestrogenic action may occur via different mechanisms. 
The first one, which is characteristic of classical antiestrogens 
(e.g. OH Tamoxifen) results from a competition with estradiol for 
binding the estrogen receptor (ER). The second one results from 
an inhibition of ER activity at its responsive element (ERE), for 
example by altering the amount of ER bound to the ERE or 
affectin g its transcriptional activity. 
With the aim of researching new antiestrogenic molecules, we 
have previously established the chimeric MVLN cell line which 
consists of stably transfected MCF-7 cells expressing the frrefl y 
luciferase in an estrogen-dependent manner. In such a model, an 
anti estrogenic effect, located at any step of the estrogenic action, 
may be evaluated . Thus, we showed that retinoic acid behaved as 
an antiestrogen and thi s effect, which did not interfere with the 
binding of estradiol to its receptor, appeared to be mediated by the 
second type of mechanism described above . 
In order to investigate the possible interactions between 
different steroid activities and the retinoid one, we developed 
MRLN cells which consist of stably transfected MCF-7 cells 
expressing the firefly luciferase in a retinoic acid-dependent 
manner. We present here some results obtained by using this 
cellular model, such as dose-dependent retinoic acid response and 
effects of the ligands of the other nuclear receptors. We also 
showed that even with only 2500 cells the luminescent response 
was detectable. These models take benefit from the well known 
advantages of the frrefly luciferase as reponer gene: detection in 
intact living cells, sensitivity and handiness. 
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HLA-DR+ EPIDERMAL CELLS STIMULATE THE SKIN-
LYMPHOCYTE REACTION IN GREATER EXTENT 
THAN CDla+ CELLS 
We examined the imponance of CDla+ HLA-DR+ Langerhans 
cells and CD I a-HLA-Dr+ epidermal cells for the stimulation of 
allogeneic and autologous T cells. Mononuclear leukocytes 
isolated from the peripheral blood of 7 healthy individuals and 7 
patients with psoriasis were enriched to 96 % by passage over 
nylon wool columns. Epidermal cells were ·isolated from the roofs 
of suction blisters by trypsinization and depletion of CDla+ and 
HLA-Dr+ cells by immunobeads. Cell enrichment and depletion 
were ascenained by FACS analysis. I x 105 enriched T cells were 
incubated for 6 days with 1 x 104 allogeneic and autologous 
epidermal cells. Cell proliferation was measured by 3H·TdR 
uptake. We found no significant difference between healthy 
controls and patients with psoriasis. In both groups depletion of 
CD I a+ epidermal cells led to decreased stimulation of T cells, 
both in the allogeneic and autologous systems. Compared to 
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CDla+ cells, depletion of HLA-DR+ epidermal cells funher 
significantly diminished T cell proliferation in controls and 
patients. We conclude that HLA-DR+ epidermal cells are more 
imponant than CD 1 a+ Langerhans cells for stimulation of both 
allogeneic and autologous T cells both in normal controls and 
patients with psoriasis . Moreover, our results indicate that there 
exists a CDl a-HLA-DR+ epidermal cell population capable to 
stimulate T cells. 
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TNFa PRODUCTION IN THE MIXED EPIDERMAL-
LYMPHOCYTE REACTION IN PSORIASIS: INFLUENCE 
OF HLA-DR+ and CDla+ STIMULATOR AND CD4+ 
RESPONDER T CELLS 
Autologous epidermal cells are able to stimulate T cells. The 
aim of our study was to measure TNFa production after depleting 
stimulator epidermal HLA-DR+ and CDla+ cells, and enriching 
CD4+ T responder cells in mixed epidermal-lymphocyte cultures . 
T cells were enriched to > 96 % CD3+ cells by passage of PBL 
over nylon wool columns, CD4+ cells were positively selected to 
80 % by immunomagnetic beads as checked by FACS analysi s. 
Epidermal cells were isolated by suction blister techniques, 
CDla+ Langerhans cells and HLA-DR+ cells were depleted by 
immunomagnetic beads. 1 x 105 CD3+ cells were incubated with 
I x 1()4 epidermal cells. in RPMI 1640110 % AB-serum for 5 days. 
TFNa was determined in cell culture supernatants by ELISA 
technique. In healthy individuals the TNFa concentration in the 
cell cultures was unaffected by depletion of either CD I a+ or 
HLA-DR+ stimulator cells. By contrast, TNFa concentrations 
dropped after depletion of both CDl a+ and HLA-DR+ cells in 
cultures of patients with psoriasis. In cultures enriched for CD4+ 
responder cells, TNFa production was only marginal in healthy 
controls, whereas in psoriasis enrichment of CD4+ responder cells 
led to increased TNFa production. We conclude that TNFa 
production in the epidermal cell-lymphocyte reaction is abnormal 
in psoriasis . Both stimulator Langerhans cells and responder 
CD4+ are imponant for TNFa production in epidermal-
lymphocyte reactions in patients with psoriasis but not in healthy 
controls. 
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RETINOIC ACID PRETREATMENT EFFECT ON 
INDUCED SKIN INFLAMMATION 
In this study, the effect of IS days retinoic acid (RA) 
pretreatment has been assessed in three types of induced skin 
inflammation: ultraviolet B (UYB) erythema, sodium lauryl 
sulfate (SLS) skin irritation and nickel contact dermatitis. 
Eighteen healthy subjects, amongst which 6 were nickel-
positive, were included in the study. Three zones (3x10 cm) were 
delineated in the middle back of each subject. One zone was 
treated with RA 0.05% (RETIN-A cream), another with a cream 
base (SKINBASE) and the third was left untreated. The products 
were applied once daily for 15 days. At the end of the 
pretreatment period, the subjects were divided in three groups of 
6. Each group was submitted to one type of skin inflammation. In 
the UYB and SLS tests, four doses of inflammatory stimuli were 
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applied on each tested zone. Quantification of erythema by 
colorimetry (parameter aOo) and measurements of transepidermal 
water loss (TEWL, integrity index of stratum corneum) were 
performed before and at the end of pretreatment, and during the 
evolution of the induced inflammatory reactions. 
At the end of the pretreatment period. no signs of irritation 
(erythema or scaling) were clinically observable. On the other 
hand, a significant increase of TEWL and aOo was detected on RA 
treated zones. indicating the presence of subclinical erythema and 
stratum corneum modifications. No statistical differences between 
pretreatments were detected on SLS induced skin reactions. The 
UYB erythema had a tendency (N.S) to be increased by the RA 
pretreatment. Clinical and biophysical evaluations showed a 
significant (p<0.05) exacerbation of nickel contact dermatitis on 
RA pretreated zones. Thus. in nickel sensitive subjects, a non 
clinically irritating skin pretreatment with RA may alter the skin 
barrier function. and hence increase susceptibility to allergens. 
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REGULATORY EFFECTS OF l,2S-DIHYDROXY-
YIT AMIN D3 AND CALCIPOTRIOL ON HUMAN 
KERA TINOCYTE CELL LINE (HACAT) 
Recent studies provide evidence that 1.25(OH)2D3 has an effect 
on the regulation of immune responses on some cells such as 
human promyelocytic leukaemia cells, normal human monocytes . 
murine monocyte/macrophage tumor cells and mouse 
keratinocytes (PAM 212) (Tani. M., Br.1.Dermatol. 1992, 126, 
266). Most, if not all of the biological actions (e.g. induction of 
cell differentiation. inhibition of cell division. modulation of 
immune functions) of 1.25(OH)2D3 (VD3) and of calcipotriol 
(CPT) are believed to be mediated by a high-affinity nuclear 
receptor (VDR) for the vitamin D hormone. 
In the present study the hyperproliferative HaCat cells were 
examined to determine whether they are targets for VD3 and for 
CPT. VD3 and CPT at 10-6 M significantly decreased the level of 
DNA synthesis, and at 10-6_1 O-li M the rate of protein synthesi s. 
HaCat cells respond to VD3 and its synthetic analogue CPT by 
modulating growth kinetics suggesting the existence of a vitamine 
D autocrine loop in this cell model to psoriatic keralinocytes. 
Funher investigations are needed to determine the effects of VD3 
and CPT on the regulation of immune response. 
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A HUMAN MODEL FOR THE HISTOLOGICAL 
EV ALUA TION OF DRUG·INDUCED BIOLOGICAL SKIN 
EFFECTS WHICH MAYBE PERTINENT TO AGING· 
RELATED SKIN CHANGES, INCLUDING PHOTO· 
DAMAGE. 
To date, most work targeting aging-related skin changes, 
including photodamage. with a view to drug development in this 
area has focused on topically applied retinoids. most notably 
tretinoin. Animal models for predicting possible clinical benefit of 
agents in this condition are currently unproven for use with non-
retinoid compounds and are of less than optimal value in the 
testing of retinoid and retinoid-like agents and their formulations . 
Our aim was to explore the use of a human skin model that may 
indicate biological activity of both retinoid and non-retinoid 
materials and could be subsequently validated as a predictor of 
clinical benefit in aging-related skin changes. 
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The model for discussion involves the use of 20-40 subjects per 
test who are treated (with/without occlusion, as necessary) on 
multiple forearm sites for 28 days according to a randomized, 
double-blind plan with a test agent, tretinoin (positive control), 
vehicle, a potent conicosteroid and a combination of the 
corticosteroid and the test agent. Punch biopsies at the end of 
treatment yield histological data concerning changes in viable 
epidermal thickness, presence of increased/decreased ground 
substance and other relevant parameters. Various other 
evaluations including clinical "pre-atrophy" determination, 
ultrasound measurements for skin thickness and density, 
transepidermal water loss, skin impedance and skin elasticity are 
perfonned in order to provide additional data which may correlate 
with histological findings . 
Available data show that the results obtained from this model 
may aid in elucidating the potential for biological skin effects of 
both retinoid and non-retinoid compounds and in decisions 
concerning their optimal concentration in, and bioavailability 
from. various formulations. Refinement and full validation of this 
model will, of course, be necessary. 
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A HUMAN BIOASSAY FOR THE IN VIVO STUDY OF 
TOPICAL RETINOIC ACID ACTIVITY 
An occlusive patch test assay has been developed for assessm~nt 
of topical retinoid action in human epidermis. PrevIOus work . With 
this assay has demonstrated marked epidermal hyperplaSia In 
nonnal skin treated with topical all-trans retinoic acid (RA) for 4 
days under "Saran Wrap" occlusion and similar effects with the 
local irritant, sodium lauryl sulfate (SLS). Time course, dose 
response and comparison with SLS, were performed with RA. 
At no time, between 1 and 4 days, could the clinical or 
histologic effects (stratum corneum compaction, epidermal and 
granular layer thickness, spongiosis, and mitotic index) of 0.1 % 
and 0.025 % cream formulations of RA be distinguished from 
each other (n = 10). An "overall response index" of retinoid 
effects was devised which amalgamates scores for erythema, 
epidennal thickness and spongiosis on a 0·12 scale. This index 
was used to generate a 4 day dose response for RA at 
concentrations from 0.001 % to 0.025 % dissolved in 70 % 
ethanoV30 % propylene glycol vehicle (n = 30). RA could ~e 
successfully differentiated from SLS at 2 days by VlTtUe of ItS 
greater ability to increase epidermal thickness, spongiosis and 
glycosaminoglycan deposition (n = 10). 
It appears that although RA and SLS produce similar epide~l 
histologic changes at 4 days, significant differences at . earlier 
time-points suggest differing mechanisms of acnon which are 
probably dependent on receptor binding in the case of RA and 
independent of receptor binding in the case of SLS. Additionally, 
this assay is able to provide potency ranking for doses of RA and 
is of use in funhering our understanding of the cutaneous 
pharmacology of this agent. 
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STRUCTURE ACTIVITY RELATIONSHIPS OF NOVEL 
SUBSTITUTED CHALCONE DERIVATIVES 
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Retinoic acid and other synthetic retinoids are now used as 
therapeutic agents in the treatment of acute promyelocytic 
leukemia and also in proliferative skin disorders. Their biological 
effects are mediated by three nuclear receptors name RARa , p 
and y. The identification of synthetic retinoids selective for each 
RAR subtype would represent a valuable tool. Such retinoids 
might target a limited number of tissues, thus decreasing their 
overall toxicity . We have tested the relative affinity of various 
chalcone derivatives for the three human recombinant receptors 
produced in infected SF9 cells using baculoviruses expressing 
RARs.The KD values of the three overexpressed receptors were in 
the range 4-6xlD-9M. Various chalcone compounds, including the 
2'substituted derivatives were obtained as potential ligands for 
affinity chromatography (BW24, BW24Cu, BW25, BW29, 
BW252). Their relative affinities was tested by competition assays 
with retinoic acid. CD367 was tested as reference compound 
displaying Ki values of 7 to IOxlO-9M. Most of these compounds 
showed a relative affinity similar to the one of Ch55 (Ki=O.4 x 
ID-6M). Introduction of a 2'acetoxy substituent had only a limited 
effect on affinity, (BW29, Ki=O.7xlD-6M) which was sharply 
reduced by substitution with the bulky 2' benzoxy group 
(Ki=14xlO-6M). None of these compounds has selective binding 
activity. The 2'3 amino propanoxyl derivative (BW26) displaying 
a Ki value of 2 to 4xlD-6M with a slight specificity towards 
hRARy, was used to the design of an affinity matrix. Biological 
activity of these compounds was also assayed by measuring the 
induction of HL60 cells differentiation by the NBT reduction test. 
Whereas the BW24 derivative and the Ch55 were strongly active, 
the other derivatives were inactive. Transactivational activity of 
some of these compounds, is now being tested in transfected COS 
cells. 
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A NEW RECONSTRUCTED EPIDERMIS MODEL 
DERIVED FROM HUMAN HAIR FOLLICLE AND DE-
EPIDERMIZED DERMIS 
Human epidermis can be reconstructed in vitro by cultivating 
hair follicles on a dermal equivalent made of collagen type I and 
living fibroblasts (Lenoir et al.1988, Dev.Biol. 130, 610-620). 
This was interpreted as a phenotypical transition of cultured outer 
root sheath cells. To assess the possible role of living fibroblasts 
in this process, we repeated the experiment by cultivating human 
hair follicles, but on de-epidermized dermis (Prunieras et al. 1979, 
Ann.Chir.Plas. 24, 357-362) . 
The cultures were kept immerged for 6 days, and thereafter were 
elevated to the air-liquid interface. A multilayered and 
differentiated epidermis was obtained by 15 days. This epidermis 
presented the characteristic features of normal human epidermis in 
vivo. A complete basal membrane with numerous 
hemidesmosomes was seen. The basal cells were well oriented 
with their main axis perpendicular to the dermo-epidermal 
junction. Spinous and granular layers could be observed, with 
numerous keratohyalin granules. Cornified layers laid on lOp of 
the cultures. By in situ hybridization, keratin k5 and klO mRNA 
was localized in the basal and suprabasal cells respectively, like in 
normal human epidermis. These results demonstrate that the 
differentiation pathway of human outer root sheath cells is 
intrinsically labile and can be shifted towards the interfollicular 
keratinocyte pattern by air exposure, even in the absence of 
dermal fibroblasts . The differentiation of reconstructed epidermiS 
is modified by retinoic acid treatment, in a dose-dependent 
manner. This culture system might thus represent a valuable and 
promising tool for pharmacological studies on in vitro 
reconstructed skin. 
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INVOLVEMENT OF PROTEIN KINASE C PATHWAY IN 
RETINOIC ACID-INDUCED TISSUE TRANSGLUT A-
MINASE EXPRESSION. DIFFERENTIAL RESPONSE 
INDUCED BY RETINOIC ACID AND SYNTHETIC 
RETINOIDS. 
Cellular differentiation and tissue transglutaminase (tTG), a 
programmed cell death marker, are both induced by retinoic acid 
(RA) in various cells as epidermal cells. This effect is likely to be 
mediated by retinoic acid receptors (RARs). Effects of chalcone 
retinobenzoic acids, Ch55 and a 4' -hydroxyl derivative, were 
studied on these two responses in human promyelocytic leukemia 
cells HL-60 and neuroblastoma cells SK-N-SH. Surprisingly, 
different dose-response curves were observed between RA and 
retinobenzoic acids on tTG expression, although those compounds 
had an identical effect on cellular differentiation. Very low 
concentrations (10- 11 M) of retinobenzoic acids induce tTG 
activity although higher concentrations of RA (l0-9M) were 
necessary to induce the same response. Moreover, at higher 
concentrations (lO-7M), RA induced tTG activity and enzyme 
concentration was five-fold higher than response induced by 
retinobenzoic acids. These agents were not partial agonists as 
shown by competition experiments. A different mechanism of 
action for RA and retinobenzoic acids effects is likely. involving 
other transduction pathways than RARs. To test for this 
hypothesis. 20 ~M H7 and 20 ~ H8. respectively protein 
kinase C (PKC) and A (PKA) inhibitors. were used. Interestingly, 
H7 was able to reduce RA-induced tTG but failed to alter this 
response when induced by retinobenzoic acids. Finally, 
synergistic effects were observed when retinobenzoic acids and 
tetradecanoyl phorbol acetate (TPA), a PKC activator, were 
associated. Involvement of PKC in RA-induced tTG expression 
could be a general phenomena in other cells as epidermal cells. 
P21 
M. Michel, L. Germain and F. Auger, H6pital du St.-Sacrement, 
Laboratoire des Grands Briiles/LOEX. Universite Laval, Quebec, 
Canada. 
PERCUT ANEOUS ABSORPTION PROPERTIES OF 
CULTURED SKIN EQUIVALENT IN VITRO: INFLUENCE 
OF KERATINOCYTE CONCENTRATION AND CULTURE 
CONDITIONS 
Percutaneous absorption is one of the most important biological 
function of the skin; skin layers, particularly the stratum corneum, 
play an imponant role in skin barrier propenies. Skin permeability 
can be measured in vitro using Franz diffusion cells. Skin from 
hairless animals is used in most pharmacological studies. 
However, a large variability in the results is observed. 
We. produced a living human skin equivalent (SE) in vitro. 
Keraunocytes were cultured on a fibroblast popUlated collagen gel 
(Bell et aI., Science 211, 1042, 1981) and formed a stratified 
multilayer which reached a terminal differentiation state when 
cultured at an air-liquid interface. A new peripheral anchorage 
technique for these SE was established in our laboratory (Lopez-
Valle et aI., Brit.1.Dermatol, in press). This model inhibits 
collagen contraction and allows SE to be mounted on Franz 
diffusion chambers. Percutaneous absorption propenies of dermal 
equivalents and SE were measured, using benzoic acid, a 
molecule with a high permeability index. The results suggest that 
a decrease in SE permeability was proponional to the presence, 
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the growth and differentiation rate of keratinocytes in culture. In 
fact. SE cultured at an air-liquid interface were less permeable 
than immersed cultures. In all cases, histological analysis of the 
SE revealed a correlation between permeability and stratum 
corneum thickness. These results confirm that keratinocytes are 
directly involved in skin permeability, notably differentiated cells, 
forming the stratum corneum. This was the first attempt to 
optimize the cultured SE for permeability measurement for 
pharmacological and cosmetological studies. 
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CHLOROQUINE, ETHANOL 
AFFECT LYMPHOCYTE 
PATIENTS WITH PSORIASIS 
AND INDOMETHACIN 
PROLIFERATION IN 
A variety of agents including chloroquine and ethanol have been 
reponed to trigger psoriasis. Results about the correlation between 
the exacerbation of psoriasis and the medication of indomethaCin 
are contradicting. Since immunological mechanisms. are 
considered to be of great importance in the pathogenesIs of 
psoriasis, we compared the effect of different concentrations of 
chloroquine, ethanol and indomethacin on the in vitro lymphocyte 
proliferation in 15 healthy control individuals and 15 patients with 
psoriasis. The lymphocyte proliferation was monitored by the 
spontaneous and phytohemagglutin (PHA)-induced uptake of 3H-
TdR. 
Both spontaneous and PHA-driven lymphocyte proliferation 
were significantly lower in samples from patients with psoriasis. 
Spontaneous blastogenesis both in control samples and in 
psoriatic samples remained unaffected by these drugs. In PHA· 
induced cultures from controls, chloroquine diminished 
proliferation dependent on the concentration; ethanol reduced the 
proliferation by more than 50 %. By contrast, ethanol increased 
the proliferation of lymphocytes from psoriatic patients by 200· 
300 % and chloroquine increased the proliferation by more than 
300 %. Indomethacin did not stimulate the PHA-induced 
lymphocyte proliferation neither in psoriatic nor in control 
samples, on the contrary, proliferation was slightly decreased in 
both groups. 
Our data show that in psoriatic samples the lymphocyte 
transformation is unaffected by indomethacin but abnormally 
increased by the addition of chloroquine and ethanol, pointing out 
the possible impact of chloroquine and ethanol on the 
pathomechanisms of psoriasis. Ethanol and chloroquine influence 
the activation process of T-Iymphocytes of psoriasis patients in 
vitro, we assume an analogous effect on immunological pathways 
in vivo. 
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SEQUENCE COMPARISON OF THE DNA BINDING 
DOMAINS OF RAR AND RXR RETINOID RECEPTORS 
The action of retinoids is mediated by nuclear receptors, RAR 
and RXR, which belong to the superfamily of thryoid and steroid 
hormone receptors. The DNA binding domain of these receptors 
consists of two zinc fingers (4 Cys type) and is highly conserved 
within the whole family . Significant amino acid sequence 
differences are found in a region corresponding to the second 
knuckle of the first zinc finger which has been shown to be 
responsible for the hormone response element specificity. The 
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superfamily thus can be divided into two subfamilies, the 
progesterone, mineraloconicoid, androgene and glucoconicoid 
receptor family (knuckle sequence: CGSCKV) and the esrrogen. 
thyroid. vitamin D and retinoic acid receptor family (knuckle 
sequence: CEGCKG(A) ). 
Alignment of retinoic acid receptor RAR and RXR amino acid 
sequences reveals the exrreme conservation of the DNA binding 
domains. The more recently detected RXR subfamily also 
contains the consensus knuckle sequence CEGCKG. However, the 
sequence of the first knuckle of the same zinc finger is different: 
CFVCQ(N) for the RAR subfamily and CAICG for the RXR 
subfamily. Although the substitutions of phenylalanine by alanine 
and of valine by isoIeucin can be considered conservative ones. 
these and the substitution of the polar side chain of glutamine by 
the non polar side chain of glycine might have a functional 
significance. This is even more likely as the two sequences are. 
conserved even in species as distant as Homo sapiens and 
Xenopus Ieavis. It is also possible that the two sequences evolved 
from a common ancestor early in evolution before the 
development of the alpha. beta and gamma SUbtypes of each 
receptor. As a consequence. species that possess different 
receptors for the two retinoid pathways (RAR and RXR) but 
without the subtypes (alpha. beta and gamma) should exist. The 
alignment of the sequences also shows few other conservative and 
non conservative amino acid substitutions, the functional 
significance of which we still ignore. 
Supponed by grants from the Consiglio Nazionale delle Ricerche, 
AIR C and Ministero della Sanita. 
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SUPPRESSION OF COLLAGEN SYNTHESIS AND 
PROLIFERA TION OF FIBROBLASTS IN CULTURE BY 
BENZOIC HYDRAZIDE 
In confluent cultures of human skin fibroblasts, collagen 
synthesis measured as [3H]proline incorporation into collagenase-
sensitive protein was specifically inhibited by benzoic hydrazide 
(BH) in a dose- and time-dependent manner. The maximum 
inhibition (80 %) occurred in cells treated with ImM BH for 72 
hr. A number of other hydrazides as well as benzamide and ethyl 
benzoate were inactive, suggesting exrremely rigid structural 
requirements for collagen-suppressing activity. The BH effect was 
independent of the presence of ascorbic acid and the concenrration 
of serum in culture medium. BH-rreated cells regained full 
capacity to synthesize collagen when cultured for 72 hr in medium 
devoid of BH. The diminished collagen synthesis in BH-rreated 
cells correlated with a specific reduction in the level of 
procollagen mRNA (63 %). The little collagen synthesized by 
BH-treated fibroblasts was predominantly associated with the cell 
layer and was deficient in hydroxyproline (76 %), indicating 
inhibition of prolyl hydroxylation in the cell. When added to cell 
extracts, however, I mM BH had no effect on prolyl hydroxylase 
activity. Taken together, these data indicate that under the culture 
conditions BH is activated to an inhibitor of prolyl hydroxylase. In 
addition to suppressing collagen synthesis, BH reversibly 
inhibited the serum-dependent proliferation of subconfluent 
cultures without causing cytotoxicity. The antiproliferative effect 
was dependent on BH concenrration between I a ~ and I ()() 
~M, the latter resulting in almost complete cessation of cell 
proliferation. Under these conditions, phenylacetic and 
isonicotinic hydrazides had no significant effect on fibroblast 
proliferation, reflecting their inability to inhibit collagen synthesis. 
The studies reveal a requirement of collagen for fibroblast 
proliferation md offer a therapeutic potential for benzoic 
hydrazide as an antifibrotic agent. 
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EFFECTS OF ORAL CYCLOSPORIN A 




CycJosporin A (CsA) has been shown to be efficacious in 
psoriasis. CsA may theoretically improve psoriasis via inhibition 
of (T lymphocyte derived) cyrokines and of keratinocyte 
proliferation. The levels of expression of cytokines in cryostat 
sections from lesional skin of eight patients with recalcirrant 
plaque-type psoriasis were studied. CsA (SandimmuneR) was 
given orally at a dose of 5 mglkg/day. Skin biopsies were taken 
from the same psoriatic plaques, before and after 2 weeks of 
therapy. Specific antibodies to IL-Ia., IL-If), TNF-a., 1L-6, IL-8, 
IFN-y were used in an indirect immunoperoxidase staining 
technique. Antibodies to 1L-2R, T lymphocytes and some 
adhesion molecules were also included. The results showed that 
the expression of IL-I f) (but not ll..-I ex) and, to a lesser extent, of 
1L-8 were significantly reduced in the epidermis after treatment. 
The total number of T lymphocytes was significantly reduced in 
the dermal infilrrate in all CsA-treated patients. However, the 
CD4/CD8 ratio remained unaltered. As reponed by others, ll..-
2R+ and lCAM-I+ cells were almost completely depleted from 
the epidermis after two weeks of CsA treatment. These 
observations stress the role of ll..-lf), ll..-8 and T lymphocytes in 
the pathophysiology of psoriasis. 
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PANTOTHENIC ACID PRECURSOR IN WOUND 
HEALING: DOUBLE BLIND ASSESSMENT BY ULTRA-
SOUND AND HISTOLOGICAL EXAMINATION OF 
EXCISED WOUNDS 
Pantothenic acid (PA) is a component of Coenzyme A (CoA). 
CoA is vital in many biochemical reactions but is not rransponed 
across cell membranes; pantothenic acid is the mobile species. 
Dexpanthenol. the alcohol analog of PA. is absorbed by the skin 
and converted to PA. Fibroblasts cultures incubated with PA, or 
its derivatives increase 3H-thymidine incorporation. cell 
proliferation . cell migration , collagen synthesis and inrracellular 
protein synesis: the mechanism is unknown. A double blind study 
was performed to determine if topical dexpanthenol in a suitable 
base was able to accelerate wound healing. Fifteen volunteers 
aged 50 to 63 had four wounds made on the parasacral area by 
shave biopsy. Randomized wounds were created once daily for 5 
days either with I) dexpanthenol in a wlo base [BEPANTHENR 
Ointment). 2) the base alone. 3) a commercial product. or 4) 
normal saline using 0.1 ml of product on each wound. Heali ng 
was evaluated by erythema index. surface closure, and wound 
volume decrease; viscoelastic changes and histological 
examination of the excised wounds were assessed at 19 days. 
Results showed significant differences in the elasticity of the 
wounds, with the dexpanthenol rreated wounds showing the 
fastest recovery . Histologically. the dexpanthenol rreated wounds 
healed faster. and with less scarring than either the base product or 
the commercial product. This suggest a major role for PA in the 
wound repair process directed towards fibroblast activity. 
problably through a specific regulatory mechanism of collagen 
and elastin synthesis . 
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These models take benefit from the well known advantages of the 
firefly luciferase as reponer gene: detection in intact living cells, 
sensitivity and handiness . 
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VIT AMIN D RECEPTOR (VDR) COEXPRESSION WITH 
MEDIATORS OF LOCAL INFLAMMATION IN 
PSORIASIS VULGARIS: AN IMMUNOHISTOCHEMICAL 
DEMONSTRA TlON BY CONFOCAL LASER SCANNING 
MICROSCOPY 
The skin is a key tissue in both synthesis of the precursor and 
function of vitamin D3. The most potent metabolite 1.25-
dihydroxyvitamin D3 (1.25-D3) acts via binding to a nuclear 
high-affinity receptor (VDR) . . 1.25-~3 . wa~ shown to bloc::k 
proliferation and to promote dlffere~1t1auon in keraun~yte.s ill 
vitro. The efficacy of tOpiCal applIcaoon of 1.25-D3 or Vitamin D 
analogues in the therapy of psoriasis vulgaris has been shown 
recently. Proliferation and differentiation of epidermal cells are 
regulated by various growth factors, cytokines, hormones and 
corresponding receptors. A si~ni~cant increas.e in. VDR 
expression in keratinocytes and skin Immune cells In leslOnal as 
compared to nonlesional psoriatic skin was shown applyi~g an 
immunohistochemical method and the monoclonal anubody 
9A 7 Y to the VDR. Recently, we demonstrated by saturation 
analyses according to Scatchard that yD~ expre~slOn In 
keratinocytes is modulated by cytokines In Vitro. This effect 
seems to be specific since it was not linearly concordant with the 
effects of those cytokines on proliferation of keratinocytes. We 
now focused our effons to demonstrate by confocal laser scanning 
microscopy the coexpression of VDR and mediators of local 
inflammation in psoriasis vulgaris in vivo. Double staining 
procedures were performed applying the monoclonal antibody 
9A7 y to the VDR and antibodies to CD antigens, cytokines (IL-
I, NAP-IIlL-8, TNF-a, interferon y) and corresponding 
receptors. Our findings indicate that confocal laser scanning 
microscopy is a promising tool to analyse the coexpression of 
hormones, cytokines, growth factors and corresponding receptors . 
The results suggest that local 1.25-D3 concentration, VDR 
expression and cytokines might be of high importance in the 
connectivity between skin immune cells and keratinocytes in 
psoriasis vulgaris and under various other pathological conditions 
in vivo. 
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POL YMERIC MICROSPHERES AS A NOVEL TOPICAL 
SITE-SPECIFIC DRUG DELIVERY SYSTEM FOR 
TARGETING A NAPHTHOIC ACID DERIV ATIVE, 
ADAPALENE, TO THE PILO-SEBACEOUS UNIT 
In order to improve the therapeutic index of adapalene (CD 
271), a new drug under development for the treatment ofacne (1), 
site-specific drug delivery to the hair follicles using 50:50 poly 
(D,L) lactic-co-glycolic acid microspheres (PLGA microspheres) 
as particulate carriers was investigated in vitro and in vivo. 
PLGA microspheres (mean diameters: 1, 5 and 20 11m) 
containing I % of adapalene were prepared by a solvent 
evaporation technique. 
After application of aqueous gels containing 10% adapalene-
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loaded PLGA microspheres (i.e. 0.1 % w/w adapalene, fmal 
concentration) to hairless rat and human skin in vitro for 35. and 
300 minutes (static diffusion cell), cryosections of skin pieces 
were observed by fluorescence and scanning electron microscopy. 
The 5 11m microspheres were specifically targeted to the 
follicular ducts and did not penetrate the stratum corneum, 
whereas the 1 IJ.m microspheres randomly distributed into the 
stratum corneum and hair follicles. The largest microparticles (20 
11m) remained on the stratum corneum surface. 
An aqueous gel containing 10% of adapalene-Ioaded 
microspheres was not irritating in a rabbit skin irritancy. teSL A 
dose-related comedolytic activity of topical formulanons of 
adapalene-Ioaded microspheres was observed in the rhino mouse 
model (2). 
The in vitro release of adapalene from the microspheres in 
artificial sebum at 37"C was much faster than the in vivo sebum 
excretion in humans (8 days), with a half-life of about 60 minutes. 
After topical application of an aqueous gel containing 
adapalene-loaded PLGA microspheres (5 11m) t.o human 
volunteers, site-specific drug delivery was funher eVidenced by 
follicular biopsy. 
Drug follicular targeting using polymeric microspheres (3) may 
represent a promising and valuable therapeutic approach for 
pathologies associated with pilo-sebaceous structures. 
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IN VITRO RELEASE OF ADAPALENE FROM 
DIFFERENT TOPICAL DRUG DELIVERY SYSTEMS 
There is a need for rapid and reliable in vitro methods for 
assessing drug release from topical dosage forms. These tests 
should allow accurate comparisons of drug release profiles from 
experimental topical formulations and also constitute a 
standardized methodology for assuring batch-to-batch uniformity 
(1 , 2) . 
The release of a new drug developed for the treatment of acne 
(3), adapalene (CD 271) from various topical drug delivery 
systems was analysed in vitro using an automated flow-through 
diffusion cell (4). The influence of receptor fluid polarity, 
synthetic membrane characteristics, occlusion and formulation 
composition, on adapalene release was evaluated by calculation of 
the apparent release constant and lag-time from the release 
profiles. 
The release rate of adapalene from an anionic oil-in-water 
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emulsion and an aqueous gel was independent of the amount of 
tested formulation . It was, however, highly dependent on the type 
of formulation (lotion, aqueous or hydroalcoholic gel, anionic or 
non-ionic oil-in-water cream, polymeric microspheres). 
Adapalene release from the different formulations increased 
proportionally to the receptor fluid lipophilicity (isopropyl 
myristate >n-octanol >aqueous sUlfactant solution). The 
characteristics of the synthetic membrane also influenced 
adapalene release profiles and drug pharmaceutical availability 
was greatly enhanced under occlusion for drug delivery systems 
containing volatile solvents. 
The in vitro automated release test proposed in the present 
study, with a membrane-receptor phase combination and a 
standard procedure adapted to the drug and dosage form physico-
chemical characteristics, represents a valuable and reproducible 
method for screening prototype topical drug delivery systems and 
for a batch-to-batch control in the manufacturing process. 
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PREPARATION AND EVALUATION OF 
DERMATOLOGICAL FORMULATIONS BASED ON 
INCLUSION OF TRETINOIN IN f).CYCLODEXTRIN AND 
HYDROXYPROPYL-f)-CYCLODEXTRIN 
Retinoids, panicularly tretinoin (all-trans-retinoic acid) , 
represe nt a major class of drugs in dermatology for the topical 
treatrnent of several diseases such as acne, psoriasis, ichthyosis, 
~c[inic keratoses. In order to improve the solubility and stability of 
tretinoin in aqueous topical dosage forms and concomitantly 
reduce its skin irritation potency whilst maintaining its therapeutic 
efficacy, inclusion complexes of tretinoin in either f)-cyclodexoin 
or hydroxypropyl-f)-cyclodexoin (1 ,2) were prepared as 
described by Shroot et al. (3). 
Tretinoin solubility in water was increased by inclusion in f)-
cycIodexoin and hydroxypropyl-f)-cyclodexoin by about 400 and 
5000 times, respectively, and a funher augmentation was obtained 
by using the tretinoin oiethanolamine salt. 
Aqueous solutions containing inclusion complexes of tretinoin 
with f)-cyclodexoin or hydroxypropyl-f)-cyclodexoin, jellified 
with Carbopol (tretinoin final concentration : 0.025%), were stable 
for 2 months at 45"C and for 2 years at 20"e. 
These gels were less irritant than commercial formulations of 
tretinoin in a rabbit skin irritancy test. 
Although the profiles of in vitro tretinoin release from the 
cyclodexoin drug delivery systems were different from those of 
commercial formulations, in vitro drug penetration kinetics 
through hairless rat or human skin were found to be similar. 
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An aqueous gel containing tretinoin/f)-cyclodextrin inclusion 
complex presented a comedolytic activity at least equivalent to 
that of a commercial hydroalcoholic gel (Aberel 0.025%) in the 
rhino mouse model (4). 
This aqueous gel was also as effective as the commercial 
formulation in the topical treatment of patients with acne vulgaris 
and was better tolerated with in particular reduced irritation. 
Cyclodexoins represent a promising advance in dermatology as 
they enhance significantly the solubility of lipophilic drugs such 
as retinoids in water and thus permit the use of totally aqueous 
formulations . They may also protect drugs from oxidation, photo· 
decomposition and improve their therapeutic index by either 
reducing toxic side-effects or modifying drug bioavailability. 
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The hydrolysis of membrane phosphoinositides is an imponant 
signal transduction pathway coupled to cell surface receptors and 
is suggested to playa role in cell proliferation and differentiation. 
In the present investigation, the environmental contaminant 2, 3, 
7, 8-tetrachlorodibenzo-p-dioxin (TCDD) was studied for its 
effect on the inositol phosphate pathway in the human 
keratinocyte cell line SCC-12F. TCDD did not act directly on this 
pathway to alter inositol phosphate metabolism. Using bradykinin 
as external activator, pretreatment of SCC-1 2F cells with 10 nM 
TCDD for 48 h resulted in an attenuated formation of inositol I, 4, 
5-oisphosphate as compared to vehicle controls (52% reduction). 
In contrast, TCDD pretreatment yielded an enhanced response 
(35% increase in inositol monophosphates as compared to 
vehicle-treated controls) in the presence of the calcium ionophore 
A23187 or the combination of 20 nM NaF ar- -' '0 IJ.M AlCI3 
whIch IS known to form A1F4-, a putative GTP nllmicking agent. 
These results indicate that TCDD pretreatmen' ..:an alter the 
responsiveness of the inositol phosphate signal transduction 
pathway to both external effectors and intracellular modulators of 
inositol phosphate formation. Modulation of the inositol 
phosphate - mediated signal transduction might conoibute to 
TCDD - induced alterations in patterns of growth and 
differentiation in keratinocytes. 
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CYCLOSPORIN A OR ETRETINATE TREATMENT 
NORMALIZE THE DECREASED BINDING OF cAMP TO 
PROTEIN KINASE A IN ERYTHROCYTE MEMBRANES 
OF PATIENTS WITH PSORIASIS 
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During a therapeutic study with etretinate compared to 
cyclosporin A in psoriasis the effects of these agents on the 
binding of cAMP to the regulatory subunit RI of protein kinase-A 
in erythrocyte membranes were investigated by determining the 
UV -light catalyzed incorporation of tritiated azido-cAMP into 
protein kinase-A of isolated erythrocyte membranes. Erythrocyte 
membranes from 10 healthy individuals served as controls. The 
evaluation was done by Scatchard plots. The method allowed the 
calculation of the maximal binding capacity and also of the 
dissociation constant Kd. In 10 psoriatics treated with etretinate 
and 21 psoriatics treated with cycJosporin A the binding capacity 
of the protein kinase for cAMP was definitely decreased and 
returned to normal after treatment for 10 weeks. Over this period 
there was a significant correlation between the psoriasis area-and-
severity index (PAS!) and the maximal binding capacity. The Kd 
values, however, remained unchanged before and after treatment. 
These results found in erythrocytes with a survival time of 120 
days indicate a non-competitive inhibition of the cAMP binding 
rather than a genetic defect. The inhibitor seems to disappear 
during effective treatment of psoriasis either with etretinate or 
cyclosporin A. 
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EXPRESSION OF · PSORlASIN mRNA IN SEVERAL 
HUMAN SKIN DISEASES 
Psoriasin is a small protein with a potential Ca-binding site but 
with as yet no known function . It was recently found to be 
expressed at high levels in keratinocytes from psoriatic plaques 
but only weakly in keratinocytes from normal skin (1. Invest. 
Dermatol. 97:701, 1991) . We have therefore investigated, by iD. 
situ hybridisation, the mRNA distribution of psoriasin in five 
additional skin diseases: mycosis fungoides, atopic dermatitis, 
lichen sclerosus et atrophic us, M. Darier and ichthyosis vulgaris. 
Riboprobe templates were generated by PCR using self priming 
oligonucleotides spanning 150 bp of the 3' -end of the published 
gene sequence flanked by 17- and T3-promotors. In situ 
hybridisation was performed by standard procedures using~ 
labelled antisense riboprobes and sections made from routinely 
formalin fixed and paraffin embedded clinical biopsy material. A 
similarly designed riboprobe derived from the human cytokeratin 
I gene (K I) served as positive control and sense probes of both 
templates as negative controls. 
Consistent with published results, we observed strong 
expression of psoriasin mRNA in the epidermis of psoriatic 
plaques. Funhermore. compared to K I-expression, strong to 
moderate signals were found in mycosis fungoides, atopic 
dermatitis, M. Darier and, in some cases, in lichen scJerosus et 
atrophic us. Expression was much weaker in involved psoriatic 
skin and not detectable in ichthyosis vulgaris and normal skin. In 
all cases, psoriasin expression correlated with the existence of 
subepidermal perivascular cellular infiltrates. In general, signals 
were clearly suprabasal with an increased expression towards the 
cornified layer. 
These results show that "psoriasin" is not restricted to psoriasis, 
but that it can also be found in other inflammatory skin diseases. 
Although its particular role awaits elucidation, psoriasin may be 
imponant in the molecular mechanisms underlying the 
pathogenesis of inflammatory skin diseases. 
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DOES TOPICAL APPLICATION OF 1,25·DIHYDROXY. 
VIT AMIN D3 NORMALIZE EPIDERMAL DIFFEREN. 
TIATION IN PSORIASIS? 
29 patients suffering from chronic plaque psoriasis were treated 
with ointments containing 3 Ilg/g 1,25(OH)2D3 (calcitriol) or 
placebo in a within-patient, left-right, comparative, double-blind , 
randomized study. The ointments were applied twice dail y to 
symmetrical, bilateral, severe psoriatic plaques for 6 weeks or 
until clearance of one of the side, whichever was the shonest. 
For hi stological and immunological investigation, skin punch-
biopies were taken from the center of each chosen psoriatic 
plaques before and after the treatment. Skin samples were divided 
into two fragments. One of them underwent standard histological 
hematoxylin-eosin staining and the second one was preserved for 
direct or indirect immunological evaluation using monoclonal 
antibodies CD IS , CD 16, CD 36, CD la, Ki 67 . 
Clinical results revealed complete clearance or considerable 
improvement in 71.5 % of calcitriol treated sides and in 31 % of 
placebo. Local and systemic tolerance and safety of twice daily 3 
Ilg/g calcitriol ointment was satisfactory. 
Histological evaluations before and after the treatment clearly 
showed bener re sults under influence of 1.25-dihydroxyvitamin 
D3 than placebo, however very good and good results were 
obtained on both sides of the body, but epidermal normalization 
was histologically more evident in calcitriol ointment treated 
plaques. 
Immunopathological study was performed in small group of 
patients. Nevenheless strongly positive pemphigus-like reaction in 
all biopsies before treatment (CD 36), negative staining with 
monoclonal antibody (m.a.) CD la, strongly positive reaction with 
m.a. CD 15 and CD 16 and normalization of these pictures with 
calcitriol therapy suggest its essential influence on epidermal 
proliferation and differentiation. 
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IDENTIFICATION AND MODULATION BY RETINOIC 
ACID OF DRUG METABOLIZING ENZYMES PRESENT 
IN CULTURED HUMAN SKIN 
Although enzymatic activities in the skin can be a key factor 
for the toxicity of topically applied drugs, little is kown about the 
xenobiotic metabolizing enzymes present in human keratinocytes. 
Recently, we have detected both phase I and Phase II drug 
metabolizing activities in an in vitro reconstituted epidermis (M.-
A. Pham et aI., lInvest.Dermatol. 94, 749-752, 1990). Using 
western blots and a chemiluminescent detection procedure, we 
now identified, in normal human keratinocytes grown in culture, 
i) phase I enzymes, namely cytochrome P450 lAl (60 kDa) and 
NADPH-reductase (78 kDa), and ii) phase II enzymes, namely 
UDP-glucuronosyltransferase (64 kDa), and the pi form of 
gluthathion-S-transferase (23 kDa). With the exception of GSTpi, 
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expression of these enzymes was not only inducible by 3-
methylcholanthrene and dimethylbenz(a)anthracene, but also by 
retinoic acid. 
To better understand the regulation of cytochrome P450 lAl 
expression in human keratinocytes, we transfected into these cells 
CA T constructs containing all or parts of the regulatory region of 
the lAI gene, cloned ahead of the CAT gene (Hines et aI., 
Carcinogenesis 9, 1599-1605, 1988). By functionally scanning 
this regulatory region in the presence of different inducers, we 
confIrmed that the previously identified xenobiotic responsive 
elements (XRE) were active in keratinocytes. 
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VEHICLE CONTROLLED STUDY OF CD 271 LOTION IN 
THE TOPICAL TREATMENT OF ACNE VULGARIS 
CD 271 is a synthetic, naphthoic acid derivative. It is a 
powerful modulator of epidermal differentiation with a retinoid-
like activity. 
This double blind randomized study compared the efficacy 
and safety of CD 271 0.1 % lotion to its vehicle base alone. Two 
parallel groups of male acne patients were treated twice daily for 8 
weeks with CD 271 0.1 % lotion (15 patients) or vehicle (15 
patients) on their facial acne. Efficacy was assessed by changes in 
individual lesion counts. Skin reactions were scored from 0 to 3 
for erythema, dryness, pruritus and burning at week 1, week 2, 
week 4 and week 8 of treatment. Twenty-nine cases completed the 
study and the single drop-out was due to an infections disease not 
re lated to treatment. 
Analysis of efficacy results showed that at the end of the 
treatment period : 
- Non inflammatory lesions (open + closed comedones) were 
significantly more reduced (p<O.OI) with CD 271 0.1% lotion 
(66% reduction) than with vehicle (30%). 
-Inflammatory lesions (papules + pustules + nodules + cysts) were 
also significantly more reduced (p<O.Ol) with CD 2710.1 % lotion 
(35% reduction) than with vehicle (11 %). 
-Reduction of total lesion counts was significantly greater with 
CD 271 0.1 % lotion than with vehicle (p<O.Ol) (59% and 2S% 
reduction respectively). 
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Erythema, dryness and burning were generally mild and 
clinically acceptable with CD 271 0.1 % lotion, although these 
effects were significantly higher than with vehicle (p<O.OI). 
Intensity of pruritus was significantly more pronounced with CD 
271 0.1 % lotion than with vehicle at week 8 only, however, this 
side effect was never severe. 
No CD 271 could be detected in blood plasma at the end of 
the 2 month treatment period (detection limit = lng/mI). 
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RETINOIC ACID-INDUCED GLANDULAR METAPLASIA 
IN MOUSE SKIN AND RARs EXPRESSION 
Using in situ hybridization , the expression of the nuclear 
retinoic acid receptors, RAR a, ~, and y, and of the cellular 
retinoic acid binding protein I (CRABP I) has been established 
during normal mouse skin morphogenesis, as well as after 48 h of 
retinoic acid (16.5 x 10-6 M) treatment of upper lip skin of 13.S-
day mouse embryos in vitro. 
The transcripts of RAR a and of RAR 'Y genes are abundant 
in dermal cells at the two precise stages at which these cells are 
known to elicit epidermal placode formation (12.5 days) and 
follicle morphogenesis (l3.S days) . In epidermal cells, the 
distribution of RAR y transcripts increases in parallel with the 
differentiation of the hair follicle. It should be noted that the 
CRABP gene seems not to be expressed at a noticeable level until 
the completion of skin morphogenesi s (lS.5 days). The RAR ~ 
signal is barely above background at all these stages. In contrast, 
the addition of RA provokes a significant up-regulation of the 
RAR ~ gene in the dermis, followed by the initiation of an 
alteration of hair vibrissa development , leading to an exocrine-
type gland morphogenesis . 
These results sugges t a role for retinoic acid and for its 
receptors in the epidermal-dermal interactions leading to the 
differentiation of cutaneous appendages, while the CRABP I 
appears to act in sequestering retinoic acid in skin regions which 
are not longer involved in morphogenetic processes. 
